GTCR already owns the second largest medical device coatings manufacturer, Biocoat, and the FTC holds market monopoly ...

In the FTC’s first merger challenge of the new administration, the FTC voted 4-0 last week to challenge the proposed ...

The Federal Trade Commission sued to block private equity firm GTCR BC Holdings' acquisition of medical device coating company Surmodics on Thursday, alleging the deal is anticompetitive because ...

Gifting allows recipients to access the article for free. The U.S. Federal Trade Commission has moved to block private-equity firm GTCR’s acquisition of Surmodics Inc., saying the deal would ...

is set to defend its planned merger with affiliates of GTCR LLC in court, following the U.S. Federal Trade Commission’s (FTC) move to oppose the acquisition. According to InvestingPro data, ...

GTCR announced its acquisition of Surmodics for $627 million GTCR invested in Biocoat, a specialty manufacturer of hydrophilic biomaterial coatings, services and dip-coating equipment for medical ...

Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR.

Surmodics, Inc. SRDX recently provided a statement in response to the U.S. Federal Trade Commission (“FTC”) blocking the proposed acquisition of Surmodics by funds affiliated with GTCR LLC (“GTCR”).